0 positive, 0 negative
||Focused on private, entrepreneurial companies, the BioVentures funds are designed to finance, structure and support those companies MPM believes will become industry leaders. Their charters are to invest across the spectrum of opportunities from financing start-ups to leading private equity financings of public companies. MPM's venture capital resources reflect the increasing specialization and complexity of the fast evolving healthcare space, with a team that has proven track records in venture capital, biotechnology and pharmaceutical research, business development, marketing and sales and the general management of leading industry companies. The MPM BioVentures team is headquartered at two locations - Boston and San Francisco - both centers of innovation where we can monitor technical breakthroughs and swiftly respond to market opportunities. The four MPM BioVentures funds comprising the Firm's venture capital activities, BioVentures I, BioVEntures II, BioVentures III, and most recently, BioVentures IV today represent over $2.5 billion in committed capital. All four funds are designed to invest primarily in the U.S., and secondarily in Europe and Asia, with investments that range from $5 - $60 million per portfolio opportunity.